Wasatch BioLabs, Agilent to scale native-read targeted sequencing for precision multi-omics

By on    Medical Devices & Diagnostics  

Wasatch BioLabs, Agilent to scale native-read targeted sequencing for precision multi-omics

Wasatch BioLabs has announced a co-marketing agreement with Agilent Technologies to expand access to its Direct Targeted Methylation Sequencing (dTMS) platform. The partnership integrates Agilent’s SureSelect and Avida enrichment chemistries with Wasatch BioLabs’ Oxford Nanopore-based native-read workflow, aiming to streamline high-throughput targeted sequencing for research use only (RUO) and translational settings. The announcement marks a […]

Waskyra approved for Wiskott-Aldrich syndrome: What it means for stem cell alternatives

By on    Pharma & Biotech  

Waskyra approved for Wiskott-Aldrich syndrome: What it means for stem cell alternatives

Fondazione Telethon has received regulatory approval from the United States Food and Drug Administration for Waskyra (etuvetidigene autotemcel), an ex vivo gene therapy designed to treat Wiskott-Aldrich syndrome, a rare X-linked primary immunodeficiency. This approval makes Waskyra the first gene therapy for this condition cleared for use in the United States and solidifies Fondazione Telethon’s […]

1 2 3